Evaluation of the Evolution of Quality of Life in Relation to Naso-sinus Symptomatology Under Treatment With CFTE Modulators in Children Aged 6 to 11 Years With Cystic Fibrosis With Compatible Mutation

NCT05581056 · clinicaltrials.gov ↗
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hospices Civils de Lyon